Showing results (281-290 of 314) with videos related to
Sort By:
Pageof 32
European Urology Focus|May 10, 2021
Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysisMichael Lardas, Nikos Grivas, Thomas P A Debray, et al.Prostate International|August 23, 2017
Report of the Second Asian Prostate Cancer (A-CaP) Study MeetingChoung-Soo Kim, Ji Youl Lee, Byung Ha Chung, et al.European Urology|March 9, 2020
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic ReviewLisa Moris, Marcus G Cumberbatch, Thomas Van den Broeck, et al.Journal of Medical Genetics|April 14, 2016
Microduplications at the pseudoautosomal SHOX locus in autism spectrum disorders and related neurodevelopmental conditionsMaria Tropeano, Deirdre Howley, Matthew J Gazzellone, et al.European Journal of Cancer (Oxford, England : 1990)|March 8, 2021
Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survivalKen Chow, Justin Bedő, Andrew Ryan, et al.Asia-Pacific Journal of Clinical Oncology|April 17, 2024
Management of advanced prostate cancer in the Asia-Pacific region: Summary of the Asia-Pacific Advanced Prostate Cancer Consensus Conference 2023Edmund Chiong, Declan G Murphy, Nicholas Buchan, et al.Nature Communications|January 10, 2017
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectoriesRenea A Taylor, Michael Fraser, Julie Livingstone, et al.European Urology|April 28, 2023
Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic ReviewGiancarlo Marra, Geert J L H van Leenders, Fabio Zattoni, et al.European Urology Oncology|January 11, 2021
A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further ResearchAnthony S Bates, Jennifer Ayers, Nikolaos Kostakopoulos, et al.European Urology Oncology|December 7, 2023
Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate CancerJames P Buteau, Daniel Moon, Michael T Fahey, et al.Pageof 32